The global sulfasalazine market is expected to grow at a CAGR of 3.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of inflammatory bowel disease (IBD) and other chronic inflammatory conditions such as ankylosing spondylitis and rheumatoid arthritis.
The enteric sugar coated tablet segment is expected to account for the largest share in the global sulfasalazine market during the forecast period, owing to its easy administration and low side effects. The filcoated tablet segment is expected to witness a significant growth rate during the forecast period due to its ease of administration and low side effects.
Crohn's Disease accounted for the largest share in terms of application in 2017, followed by ulcerative colitis (chronic nonspecific ulcerative colitis). Ankylosing spondylitis accounted for a small share in 2017 but is anticipated to grow at a significant rate during 2020-2030 due its high prevalence among people aged 15-45 years old.
Some Of The Growth Factors Of This Market:
- Sulfasalazine is a drug that is used to treat inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
- It is also used to treat rheumatoid arthritis and lupus erythematosus.
- The drug has been in use since the 1950s and it was approved by the FDA in 1958 for use in humans.
- Sulfasalazine can be taken orally or intravenously depending on the severity of the condition being treated and how quickly it needs to be effective for treatment purposes.
- The drug works by inhibiting an enzyme called dihydropteroate synthase which helps produce folic acid from folate which then helps produce DNA, RNA, and other important substances that are needed for cell growth.
Industry Growth Insights published a new data on “Sulfasalazine Market”. The research report is titled “Sulfasalazine Market research by Types (Enteric Sugar Coated Tablet, Film-Coated Tablet, Other), By Applications (Crohn's Disease, Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis), Ankylosing Spondylitis, Other), By Players/Companies Crescent Pharma Limited, Pfizer, Saaz-DS, KRKA, Vintage, Qualitest, NPS Medicinewise, Kamp Medicine, Hubei Wudang, Hebei Yinengpu, Shanxi Wanshou, Fujian Fukang, Guangzhou Huahai, WATSON LABS, Pharmacia & Upjohn, Chongqing Dikang, Shanghai Xinyi Tianping Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sulfasalazine Market Research Report
By Type
Enteric Sugar Coated Tablet, Film-Coated Tablet, Other
By Application
Crohn's Disease, Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis), Ankylosing Spondylitis, Other
By Companies
Crescent Pharma Limited, Pfizer, Saaz-DS, KRKA, Vintage, Qualitest, NPS Medicinewise, Kamp Medicine, Hubei Wudang, Hebei Yinengpu, Shanxi Wanshou, Fujian Fukang, Guangzhou Huahai, WATSON LABS, Pharmacia & Upjohn, Chongqing Dikang, Shanghai Xinyi Tianping Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Sulfasalazine Market Report Segments:
The global Sulfasalazine market is segmented on the basis of:
Types
Enteric Sugar Coated Tablet, Film-Coated Tablet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Crohn's Disease, Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis), Ankylosing Spondylitis, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Crescent Pharma Limited
- Pfizer
- Saaz-DS
- KRKA
- Vintage
- Qualitest
- NPS Medicinewise
- Kamp Medicine
- Hubei Wudang
- Hebei Yinengpu
- Shanxi Wanshou
- Fujian Fukang
- Guangzhou Huahai
- WATSON LABS
- Pharmacia & Upjohn
- Chongqing Dikang
- Shanghai Xinyi Tianping Pharmaceutical
Highlights of The Sulfasalazine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enteric Sugar Coated Tablet
- Film-Coated Tablet
- Other
- By Application:
- Crohn's Disease
- Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
- Ankylosing Spondylitis
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sulfasalazine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sulfasalazine is a medication used to treat inflammatory bowel disease (IBD). It works by reducing the inflammation and pain caused by IBD. Sulfasalazine is also known as sulfa-salicylate.
Some of the major players in the sulfasalazine market are Crescent Pharma Limited, Pfizer, Saaz-DS, KRKA, Vintage, Qualitest, NPS Medicinewise, Kamp Medicine, Hubei Wudang, Hebei Yinengpu, Shanxi Wanshou, Fujian Fukang, Guangzhou Huahai, WATSON LABS, Pharmacia & Upjohn, Chongqing Dikang, Shanghai Xinyi Tianping Pharmaceutical.
The sulfasalazine market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sulfasalazine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sulfasalazine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sulfasalazine Market - Supply Chain
4.5. Global Sulfasalazine Market Forecast
4.5.1. Sulfasalazine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sulfasalazine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sulfasalazine Market Absolute $ Opportunity
5. Global Sulfasalazine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sulfasalazine Market Size and Volume Forecast by Type
5.3.1. Enteric Sugar Coated Tablet
5.3.2. Film-Coated Tablet
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sulfasalazine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sulfasalazine Market Size and Volume Forecast by Application
6.3.1. Crohn's Disease
6.3.2. Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
6.3.3. Ankylosing Spondylitis
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sulfasalazine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sulfasalazine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sulfasalazine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sulfasalazine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sulfasalazine Demand Share Forecast, 2019-2026
9. North America Sulfasalazine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sulfasalazine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sulfasalazine Market Size and Volume Forecast by Application
9.4.1. Crohn's Disease
9.4.2. Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
9.4.3. Ankylosing Spondylitis
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sulfasalazine Market Size and Volume Forecast by Type
9.7.1. Enteric Sugar Coated Tablet
9.7.2. Film-Coated Tablet
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sulfasalazine Demand Share Forecast, 2019-2026
10. Latin America Sulfasalazine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sulfasalazine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sulfasalazine Market Size and Volume Forecast by Application
10.4.1. Crohn's Disease
10.4.2. Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
10.4.3. Ankylosing Spondylitis
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sulfasalazine Market Size and Volume Forecast by Type
10.7.1. Enteric Sugar Coated Tablet
10.7.2. Film-Coated Tablet
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sulfasalazine Demand Share Forecast, 2019-2026
11. Europe Sulfasalazine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sulfasalazine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sulfasalazine Market Size and Volume Forecast by Application
11.4.1. Crohn's Disease
11.4.2. Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
11.4.3. Ankylosing Spondylitis
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sulfasalazine Market Size and Volume Forecast by Type
11.7.1. Enteric Sugar Coated Tablet
11.7.2. Film-Coated Tablet
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Gowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sulfasalazine Demand Share, 2019-2026
12. Asia Pacific Sulfasalazine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sulfasalazine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sulfasalazine Market Size and Volume Forecast by Application
12.4.1. Crohn's Disease
12.4.2. Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
12.4.3. Ankylosing Spondylitis
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sulfasalazine Market Size and Volume Forecast by Type
12.7.1. Enteric Sugar Coated Tablet
12.7.2. Film-Coated Tablet
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sulfasalazine Demand Share, 2019-2026
13. Middle East & Africa Sulfasalazine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sulfasalazine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sulfasalazine Market Size and Volume Forecast by Application
13.4.1. Crohn's Disease
13.4.2. Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
13.4.3. Ankylosing Spondylitis
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sulfasalazine Market Size and Volume Forecast by Type
13.7.1. Enteric Sugar Coated Tablet
13.7.2. Film-Coated Tablet
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sulfasalazine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sulfasalazine Market: Market Share Analysis
14.2. Sulfasalazine Distributors and Customers
14.3. Sulfasalazine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Crescent Pharma Limited
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Saaz-DS
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. KRKA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Vintage
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Qualitest
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NPS Medicinewise
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Kamp Medicine
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Hubei Wudang
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hebei Yinengpu
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Shanxi Wanshou
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Fujian Fukang
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Guangzhou Huahai
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. WATSON LABS
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Pharmacia & Upjohn
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Chongqing Dikang
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Shanghai Xinyi Tianping Pharmaceutical
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
